SOURCE: Threshold Pharmaceuticals

Threshold Pharmaceuticals

September 03, 2015 07:00 ET

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 3, 2015) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Rodman & Renshaw Annual Global Investment Conference on September 10, 2015, at 11:15 a.m. Eastern Time.

A live webcast of the presentation will be available under Webcasts in the Investors section of www.thresholdpharm.com. A replay of the presentation will be archived on the site for 30 days.

About Threshold Pharmaceuticals

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the bone marrows of some patients with hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (www.thresholdpharm.com).

Contact Information